Phesgo (chemical name: pertuzumab, trastuzumab, and hyaluronidase-zzxf) is a fixed-dose combination of Herceptin (chemical name: trastuzumab), Perjeta (chemical name: pertuzumab), and hyaluronidase-zzxf to treat all stages of HER2-positive breast cancer in combination with
chemotherapy
.
Is Perjeta chemo?
PerjetaTM is an
anti-cancer
(“antineoplastic” or “cytotoxic”) chemotherapy drug. This medication is classified as an “antineoplastic agent and a monoclonal antibody”.
Is perjeta a chemo drug?
Perjeta (chemical name: pertuzumab) used in combination with Herceptin (chemical name: trastuzumab), another targeted therapy medicine, and Taxotere (chemical name: docetaxel), a type of chemotherapy, to treat HER2-positive, metastatic breast cancer that hasn’t been treated with either Herceptin or chemotherapy yet.
Is Herceptin considered chemo?
Herceptin is an intravenous drug that is part of a
chemotherapy regimen
that is used to prevent recurrence of breast cancer, and for the treatment breast cancer that has spread beyond the breast (metastasized). It belongs to a class of drugs called monoclonal antibodies.
What kind of drug is Perjeta?
In some cases, health care professionals may use the trade name PerjetaTM when referring to the generic drug name Pertuzumab. Drug Type: Pertuzumab is an
anti-cancer (“antineoplastic” or “cytotoxic”) chemotherapy drug
. This medication is classified as an “antineoplastic agent and a monoclonal antibody”.
How effective is perjeta?
94.1% of
the women in the Perjeta treatment group were alive with no cancer recurrence. 93.2% of the women in the standard treatment group were alive with no cancer recurrence.
How long can you take perjeta?
Official Answer. When Perjeta (generic name: pertuzumab) and Herceptin (generic name: trastuzumab) are used to treat HER2+ early breast cancer as adjuvant treatment (after surgery), this regimen may be continued
every 3 weeks for one year (up to 18 cycles)
.
Does PERJETA cause fatigue?
Perjeta side effects
hair loss. low white blood cell count (neutropenia) nausea. fatigue.
Is Kadcyla chemotherapy or immunotherapy?
What Is Kadcyla? Kadcyla (ado-trastuzumab emtansine) is a new class of
chemotherapy drug
called an antibody-drug conjugate used to treat breast cancer.
Does PERJETA alone cause hair loss?
Hair thinning or hair loss
Pertuzumab and trastuzumab
do not usually cause people to lose their hair
. Any hair loss caused by chemotherapy should be temporary and in most cases your hair will begin to grow back once your chemotherapy has ended.
Is chemo necessary for HER2-positive?
Trastuzumab
and chemotherapy are even recommended for women with very small, HER2-positive breast cancers. Tumors as small as 0.5 cm often warrant such treatment. However, decisions must be individualized based on your own individual risk.
Will my hair grow back while on Herceptin?
Your hair may thin but you’re unlikely to lose all your hair. This usually starts after your first or second cycle of treatment. It is almost always temporary and
your hair will grow back when you finish your treatment
.
Does Herceptin work without chemo?
Certain women age 70 to 80 may be able to skip chemotherapy after surgery
for early-stage HER2-positive disease and be treated only with Herceptin (chemical name: trastuzumab), according to a study.
Does PERJETA cause joint pain?
Some people being treated with Perjeta experience
side effects
such as muscle or joint pain, chills, and rash that should be immediately brought to the attention of the healthcare provider administering treatment.
Can PERJETA cause neuropathy?
Perjeta (chemical name: pertuzumab), Kadcyla (chemical name: T-DM1 or ado-trastuzumab emtansine), and Ogivri (chemical name: trastuzumab-dkst), targeted therapies, can also
cause neuropathy
.
What is PERJETA used for?
PERJETA, along with Herceptin
®
(trastuzumab) and docetaxel, is a first-line treatment for
HER2+ breast cancer that has spread to other parts of the body (metastasized)
. This will be given to you if you have not received anti-HER2 therapy or chemotherapy for metastatic breast cancer (first line).
